Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: Interim results from a multicenter phase I/II trial

Charu Aggarwal, Amy Prawira, Scott Antonia, Osama Rahma, Anthony Tolcher, Roger B. Cohen, Yanyan Lou, Ralph Hauke, Nicholas Vogelzang, Dan P Zandberg, Arash Rezazadeh Kalebasty, Victoria Atkinson, Alex A. Adjei, Mahesh Seetharam, Ariel Birnbaum, Andrew Weickhardt, Vinod Ganju, Anthony M. Joshua, Rosetta Cavallo, Linda PengXiaoyu Zhang, Sanjeev Kaul, Jan Baughman, Ezio Bonvini, Paul A. Moore, Stacie M. Goldberg, Fernanda I. Arnaldez, Robert L. Ferris, Nehal J. Lakhani

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: Interim results from a multicenter phase I/II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences